| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 3,489 | 3,558 | 3,704 | 2,413 |
| Cost of revenue (exclusive of depreciation and amortization, shown separately below) | 2,871 | 3,064 | 3,375 | 1,691 |
| General and administrative | 2,085 | 1,182 | 1,198 | 1,077 |
| Sales and marketing | 1,022 | 616 | 373 | 294 |
| Research and development | 59 | 55 | 144 | 175 |
| Depreciation and amortization | 63 | - | 12 | 343 |
| (allowance)/reversal for current expected credit loss | -20 | - | - | - |
| Total operating expenses | 3,209 | 1,853 | 1,727 | 1,889 |
| Loss from operations | -2,591 | -1,359 | -1,398 | -1,167 |
| Other income | 731 | 13 | 111 | - |
| Interest expense | -32 | -21 | -413 | -80 |
| Foreign exchange loss | -14 | - | - | - |
| Loss before income tax | -1,906 | -1,368 | -1,700 | -1,247 |
| Provision for income tax | - | 0 | - | 2 |
| Net loss | -1,906 | -1,368 | -1,700 | -1,249 |
| Foreign currency translation gain | 6 | - | - | - |
| Comprehensive loss | -1,900 | - | - | - |
| Basic (in shares) | 4,443,784 | 2,343,385 | 9,843,821 | 5,666,238 |
| Diluted (in shares) | 4,443,784 | 2,343,385 | 9,843,821 | 5,666,238 |
| Net loss per common share - basic, parent (in dollars per share) | -0.42 | -0.58 | -0.17 | -0.22 |
| Net loss per common share - diluted, parent (in dollars per share) | -0.42 | -0.58 | -0.17 | -0.22 |
Healthcare Triangle, Inc. (HCTI)
Healthcare Triangle, Inc. (HCTI)